The Centre is planning a few amendments to key education reform bills whose legislative progress has been stalled by opposition to several of their clauses. The Telegraph had reported how private educational institutions had been arguing that the “draconian” bills would make it difficult for new colleges and universities to be opened, and would threaten institutional heads with stringent punishment for minor mishaps. Human resource development ministry sources now say they propose...

-The Hindu Business Line A Government report has called for enhancing investment in agriculture and leveraging technology to boost the country's farm sector growth in the years ahead. The report ‘State of Indian Agriculture 2011-12,' released by the Agriculture Ministry on Tuesday, called for institutional reforms in research set up to make it more accountable and geared towards delivery, conservation of natural resources such as water and land among others. “Achieving a 8-9...

-The Economic Times The government has allowed a local drugmaker to make and sell a patented cancer drug at a fraction of the price charged by Germany's Bayer AG, setting a precedent for more such efforts by Indian firms and heightening the global pharmaceutical industry's anxiety over the use of the controversial compulsory licensing provision.  The outgoing patent controller of India, PH Kurian, on Monday granted the country's first compulsory licence to...

-The Telegraph   Chief minister Mamata Banerjee has ordered an amendment to a state law to prevent rural co-operative banks from attaching the land of loan-defaulter farmers without government approval. The directive was issued after Mamata came across two posters by a co-operative bank controlled by Trinamul Congress leaders, which sought to auction the land of farmers who have not repaid loans. “I am assuring my brothers that nobody will go to confiscate your...

In a landmark decision, India’s intellectual property office on Monday allowed Hyderabad-based Natco Pharma Ltd to make and sell a copycat version of German drug maker Bayer AG’s patented cancer treatment Nexavar. It’s the first time that an Indian company has been granted the so-called compulsory licence to market a generic version of a patented drug. The drug, patented by Bayer in India in 2008, is used in the treatment of...